Logo Image

Authors

Nicholas Jacobus
Latest Article

Incyte Announces Week 24 Results from TRuE-AD4 Phase III Trial of Opzelura

Incyte reports sustained 24-week efficacy and consistent safety data for Opzelura cream in moderate atopic dermatitis, supporting growing interest in nonsteroidal topical therapies for long-term disease control.

Bill Beldham

VP of Global Sales, PayQuicker

Latest Article

What Clinical Trials Can Learn from the Gig Economy About Payments

Outdated payment methods like prepaid cards and checks create administrative burden and retention friction, but modern flexible payment platforms with multiple payout options and global reach can improve participant experience without adding compliance complexity.

Devin Ridgley, PhD

Director, Project Management, Medical Device and Diagnostics Research, ICON

Latest Article

Clinical Strategies to Optimize Software as a Medical Device to Treat Mental Health

With close collaboration between sponsors, CROs, and regulators, this emerging technology has the potential to greatly improve the lives of patients.

Inger Ødum Nielsen, Vanessa de Langsdorff, and John April
Latest Article

How Medical Writing and Regulatory Affairs Professionals Can Embrace and Deploy Generative AI at Scale

Unlocking the full potential of artificial intelligence requires these stakeholders to ensure their data are accessible and secure.

Christine Senn, PhD, FACRP

Senior Vice President of Site-Sponsor Innovation, Advarra

Latest Article

2025 SCRS Global Site Solutions Summit Recap: Moving to True Partnerships

In this special recap of the most recent SCRS Global Site Solutions Summit, we highlight insights gained from KOLs on-site that emphasize the importance of communication and collaboration between sites and sponsors/CROs.

Niranjan Andhalkar

Director, Strategic Management & Planning, ProRelix Research

Latest Article

Risk-Based Monitoring in Global Clinical Trials: What Sponsors Must Know

Risk-based monitoring requires integrated data systems, validated analytics, and strong governance to work effectively across global trials, but sponsors face significant technical and operational challenges that demand strategic solutions and organizational alignment.

Afrah Shafquat

Senior Staff Data Scientist, Medidata Solutions

Latest Article

Accelerating Breakthroughs with Synthetic Clinical Trial Data

The emergence of AI-powered simulants in improving study efficiency.

F Sandesh Vijohar, MD; Nailesh Patel, PhD; Chirag Shah, PhD; Devanshee Patel, Pharm D; Mustafa Pardiwala, PG; and Raj Kumar, MBA
Latest Article

Overcoming Operational Challenges in Oncology Clinical Trials: Lessons from a Multicentric Study in India

Case study highlights how clinical operations teams can overcome complex regulatory and operational hurdles to finish a trial on time and on budget.

Brad Cunningham

Head of Strategic Partnerships at Verana Health

Latest Article

Tokenization: The Unsexy Plumbing of Clinical Research

As clinical research increasingly relies on RWD to enhance trial design and patient insights, tokenization has emerged as a critical solution for securely linking disparate datasets while protecting patient privacy.

Ken McFarlane

Vice President, Strategic Consulting, CluePoints

Latest Article

How AI and Advanced Statistics Are Helping Research Rise

Clinical Trials Day is an international celebration of everyone who makes medical discoveries possible. It is also an opportunity to shine a light on the innovations helping to keep research rising.

Natalie Marquess, ARM, CIC, CRM

Director - Business Development, Life Sciences at Aon

Latest Article

Clinical Trial Failure Isn’t an Inevitable Risk—It’s Insurable and Opening the Door to New Investors

Clinical trial failure insurance is turning biotech’s most costly risk into a manageable asset, opening new pathways for funding and innovation.

Farrell Healion

Founder and Principal Consultant, OptiTrial


Latest Article

Answering the Sustainability Call: Digital Health Technologies and eCOA

Sustainability should be central to clinical trial design and considerate of how digital tools such as electronic clinical outcomes assessments can help achieve this.

Kristin Tolbert

Associate VP of Health Equity Strategy at Jumo Health

Latest Article

Pregnant Women: An Underrepresented Group in Clinical Trials

Recent research is showing medical treatment for pregnant women often relies on clinical data from non-pregnant female patient populations.

Cindy Henderson

Chief Strategy Officer, Veristat

Latest Article

Navigating Complexity: Strategies to Accelerate Modern Clinical Trials

As clinical trials become more complex, success depends on early collaboration, thoughtful protocol design, and practical strategies to manage risk, reduce delays, and support patients.

Kenneth Kaitin, PhD

Professor of Medicine at Tufts University School of Medicine and Senior Fellow and former Director of the Tufts Center for the Study of Drug Development

Latest Article

Recognizing and Addressing the Execution Translation Gap in Clinical Trials

The execution translation gap—the failure to convert identified problems into coordinated, timely action—costs millions per trial through delayed amendments, persistent deviations, and slow site activation, yet remains addressable through aligned accountability and proactive execution management.

Frederic Blais, PhD

RBQM lead (strategic consulting team), CluePoints

Latest Article

Safety Reporting in RBQM: Bridging Risk Assessment, Monitoring, and Action

Safety monitoring generates substantial signal volume across risk-based quality management tools, but only 30% to 36% of signals correspond to confirmed issues, suggesting the need for better prioritization, signal consolidation, and alignment between detection and proportional action.

Mike Hutton, PhD

Director of Strategic Partnerships and Commercialisation at Almac Clinical Technologies

Latest Article

Retention by Design: Operationalizing Patient-Centric Trials Without Increasing Site Burden

The quest to turn patient retention from a chronic challenge into a competitive strength—and one that benefits all stakeholders.

Frank Jäger, Commercial Director, CCL Clinical worldwide
Latest Article

Labels That Withstand Liquid Nitrogen

Designing adhesion and durability for biopharmaceuticals in the most extreme cold chain environments.

Tom Mann

Clinical Solutions Engagement Lead, One2Treat

Latest Article

Enhancing Empowerment in Patient-Focused Research

How the inclusion of measures centered on net treatment benefit can drive an effective multifaceted approach.

Bhavish Lekh

CEO & Founder, Aurora Analytica

Latest Article

Beyond the Horizon: A New Era for Faster, Smarter Clinical Trials

Current industry trends align with the need for improved, fit for purpose technology.

Archana Hegde

Senior Director, PV Systems and Innovations, IQVIA

Latest Article

How AI and Regulation are Reshaping the Future of Drug Safety

Balancing the emerging benefits of AI in pharmacovigilance with new responsibilities and demands from regulators in enhancing efficiency and safety.

Troy Astorino

Co-founder and CTO of PicnicHealth

Latest Article

AI-Powered Non-Interventional Research Delivers What DCTs Promised

A unified technology approach improves study efficiency and data collection.

Natalia Kotchie

Senior Vice President, Applied Data Science Center, IQVIA

Latest Article

The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials

Emerging applications of AI/ML, automation, and digitization are helping sponsors cut clinical trial start-up times to as little as four weeks, reduce data errors, and enhance patient engagement—demonstrating how tech-enabled processes are reshaping trial efficiency and experience across the study lifecycle.

Raja Shankar

Vice President, Machine Learning, Research and Development Solutions, IQVIA

Latest Article

SCOPE Summit 2026: How Sponsors Are Prioritizing AI Adoption Across Clinical Trials

Raja Shankar, VP of machine learning at IQVIA, discusses which AI capabilities sponsors are most likely to adopt first to streamline trial workflows and reduce operational burden, while also highlighting emerging applications that could shape the next phase of clinical trial design.

Kevin Zeman

VP of Banking Operations, PayQuicker

Latest Article

What Clinical Trials Can Learn from the Gig Economy About Payments

Outdated payment methods like prepaid cards and checks create administrative burden and retention friction, but modern flexible payment platforms with multiple payout options and global reach can improve participant experience without adding compliance complexity.

Dinah Knotts-Keeterle

Vice President, Project Management, Vaccines and Infectious Diseases, ICON

Latest Article

From Study End to Long-Term Insight: Choosing the Right Vaccine Follow-up Strategy

Vaccine developers can reduce participant burden and extend follow-up timelines by strategically combining traditional site visits with real-world data collection, but the choice depends on follow-up duration, data requirements, and the patient population being studied.

Melissa Hutchens

Vice President, Research and Benchmarking, WCG

Latest Article

The Transformative Power of Data Analytics in Clinical Trials

Leveraging and benchmarking insights to boost efficiency and optimization.

Drew Bustos

Chief Digital Officer, YPrime

Latest Article

5 Strategies for Bridging the Sponsor-Site Tech Divide

Results from survey of 100 site personnel suggest a disconnect is present between these stakeholders.

Keri Mattox

Chief Business Officer, Parexel

Latest Article

Empowering the Workforce of the Future: The Trends and Training That Will Drive the Future of Drug Development

A new global report finds that clinical research teams are making progress but still lack the skills and tools needed to keep pace with growing trial complexity and emerging technologies.

Kirk Wroblewski

Chief Information Officer, ProPharma

Latest Article

Applied AI and Advanced Automation in Clinical Trials

Use cases spotlight the growing potential of generative AI in the CRO space.